19 march 2018
7 new patents,
Sr no
|
Patent number
|
name
|
company
|
INDICATION
|
REMARKS, WAIT FOR STR TO APPEAR
|
1
|
WO-2018048871
|
SOLRIAMFETOL
|
JAZZ
|
Cataplexy; Depression; Drug dependence; Hypersomnia; Narcolepsy; Sexual dysfunction
| |
2
|
WO-2018047131
|
ELUXADOLINE
|
SUN
|
Irritable bowel syndrome
| |
3
|
WO-2018046401
|
BETRIXABAN
|
SANDOZ
|
Phlebothrombosis
| |
4
|
WO-2018046337
|
INGENOL
|
INDENA
| Keratosis | |
5
|
WO-2018045997
|
SOFOSBUVIR
|
CHIA
|
Hepatitis C virus infection
| |
6
|
WO-2018045889
|
ORITAVANCIN
|
JHEJIANG
|
Angina; Bacterial skin infection; Enterococcus faecalis infection; Gram positive bacterium infection; MRSA infection; Streptococcus agalactiae infection; Streptococcus pyogenes infection
| |
7
|
WO-2018045505
|
SACUBITRIL
|
NORATECH
|
Cardiac failure; Hypertension; Myocardial disease
| |
8
|
WO-2018048977
|
ELECLAZINE
|
AUSPEX
|
Acute coronary syndrome; Angina; Cancer; Congestive heart failure; Diabetes mellitus; Inflammatory disease; Ischemic heart disease; Myocardial infarction
| |
Betrixaban is a long-acting anticoagulant used for the treatment of venous thromboembolism (VTE) caused by limited mobility or some other factors in adult patients. betrixaban
ReplyDeleteI have visited so many sites but I never got the site like yours, amazing posts with informative latest things.
ReplyDeleteiop program boynton beach
alcohol rehab florida